drugset / Trial / NCT04066621

PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)

NCT04066621

Phase 4 Completed 30 enrolled Xiangbei Welman Pharmaceutical Co., Ltd
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the safety and efficacy of treatment of children with acute bacterial infection disease with Ceftriaxone Sodium and Sulbactam Sodium for Injection in the condition of widely used, and provide the basis of adjusting the dosage regimen for children in particular.

Timeline

Start
2015-04-28
Primary completion
2016-06-11
Completion
2017-05-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftriaxone Other / unclassified Intravenous
Subject Sulbactam Small molecule Intravenous